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ABSTRACT
Objective: Identification of biochemical changes in ductal cancer patient’s serum samples using micro Raman spectroscopy.
Methods: Micro Raman spectroscopy was used for the identification of Raman shift bands. Data analysis was done using K-means clustering.
Results: Micro Raman spectroscopic analysis of human breast cancer patient’s serum samples was done. Biochemicals present in the samples were 
identified from the peak evaluations. K-means clustering analysis was used to differentiate the biochemicals present in the samples.
Conclusion: From the study, we conclude that Raman spectroscopy has the potential to differentiate the biochemical changes occurring in the human 
body, and the differentiation can be done using K-means clustering.
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INTRODUCTION
Raman spectroscopy is an optical technique based on inelastic scattering 
of monochromatic light, interacting with a biological specimen. While 
light beam is embattled on sample molecules, a minute portion of the 
sprinkled light undergoes shifts in its frequency. These Raman shift 
amplitudes correspond to the vibrations of intermolecular bonds. Each 
molecule has an exclusive vibrational energy state that corresponds 
to an explicit Raman shift. As such, the Raman spectrum is a direct 
function of the molecular composition of the samples, and functional 
and structural changes may be evidenced by a change in Raman optical 
signature. The wealthy information contained in Raman spectra may 
be sufficient to recognize molecular changes in a sample compared to 
reflectance or fluorescence spectroscopy. Every molecule has its own 
vibrational pattern that can provide as Raman marker to provide the 
significant biochemical information hidden in the sample [1-4].
Frontline of defense for the treatment of cancers is surgery. 
Intraoperative assessment of tissue or demarcation of tumor margins 
has relied on conventional histopathological analysis of biopsied 
tissue or physical inspection based on pre-operative images. These 
conventional techniques are defective for the discovery of minute 
or premalignant lesion which results later in tardy analysis and 
supplementary surgery. Raman spectroscopy is supposed to have the 
perspective to pick up the diagnosis of a large number of malignancies, 
together with a lot of common and lethal cancers [5].
Raman spectroscopic technique might sense the variations of molecular 
arrangement and chemical composition. Throughout the development 
of a tumor, considerable changes will occur in the configuration and 
accumulation of the main biomolecules which make up the cell and 
tissue, such as, carbohydrates, lipids, proteins, and nucleic acids. 
Since biochemical variations happen in advance, then in the clinical 
indication of manifestation and tumor medical imaging discovery, 
molecular spectroscopy shows the prospective early analysis of a 
tumor. Sharp peak characteristics, which are free from the interference 
of water fewer samples are required for sample chemical treatment. 
Raman spectroscopy is a promising tool to comprehend real-time and 
non-invasive discovery at the molecular level [6-16].
In the present study, we are trying to identify the biochemical changes 
occurring in the breast cancer patient’s blood serum samples which 
will lead to the detection of various malignancies in the early stage.
METHODS
Preparation of sample
Protocol approved by the Human Ethical Committee at Karpagam 
Faculty of Medical Sciences and Research, Coimbatore (IHE/77/
PHYSICS/03/2017), was followed for the procedures conducted. Serum 
samples from 15 ductal carcinoma patients before surgery and five 
normal persons were collected. All the serum samples were prepared 
by the same person with the same instruments.
Blood sample collection
Blood serum specimen was collected from 15 cases that were clinically 
diagnosed with cancer and five healthy volunteers. Serum was split 
from the blood by steadily stirring it with the use of a centrifuge at the 
speed of 1500 rotations/s. Samples were then stored at −80°C to avoid 
exterior interface. The use of the samples for investigation did not have 
an effect on the course of the operation or treatment of the patient.
For Raman spectral measurements of the serum sample, a drop of 40 µL 
was sited onto a silicon substrate positioned on the X-Y stage setting of a 
Witec microscope, attached to the Raman system. Raman spectrometer, 
bearing a laser wavelength of 785 nm having an irradiation power of 
17 mW, was used. The laser beam was fixed to the plane of the specimen 
with a 100x point. Raman system was calibrated with a silicon 
semiconductor using Raman peak at 529/cm.
Processing of raw Raman spectra was done by carrying baseline 
modification, smoothing and normalization to eliminate noise, sample 
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fluorescence, and short noise from cosmic rays to be finally analyzed 
using IBM SPSS software.
RESULTS AND DISCUSSION
Baseline correction
Origin 6 software was used for the baseline correction and identification 
of the peaks. The fast Fourier transform filter setup was used for 
smoothing. Number of points considered for smoothing were five. After 
this baseline, correction was done and the peak’s values corresponding 
to the peaks were identified. The resulting graph is given below.
Normal serum samples show high intensity peaks at 753, 844, 949, 
1008, 1168, 1333, 1453, 1659, 1899 cm-1, etc. Each peak indicates 
the presence of particular biochemical variation occurring in the 
human body (Fig. 1). The main band assignments found are explained, 
as 753 cm-1 corresponds to the presence of tryptophan and 844/
cm represents the presence of tyrosine. At 949 cm-1 band for amide 
III is present and at 1008 cm-1 it shows symmetric C-C aromatic ring 
breathing, at 1168 cm-1 C-C stretch in amino acid, 1333 cm-1 CH2 twist 
and bend, CH3 deformation (protein/lipid), nuclide acid, 1453 cm-1 δ 
(CH2) bending, δ (CH3) out-of-phase, 1659 cm-1 C=O stretch in amide I, 
and amino compound I alpha-helix.
In ductal carcinoma serum sample, main peak assignments are 856, 
908, 949, 1005, 1171, 1263, 1330, 1453, 1659, 1750, 1864, and 
1899 cm-1. 856 cm-1 corresponds to side chain vibrations of amino 
acid in proline and hydroxyproline as well as c-c vibrations of collagen 
backbone and tyrosine, 1005 cm-1 corresponds to phenylalanine, 1171 
corresponds to C-C stretch amino acids, 1263 corresponds to N-H 
bending in amide III, 1330 cm-1 corresponds to CH2 twist and bend, 
CH3 deformation (protein/lipid), nuclide acid, and 1750 cm-1 C = O 
stretch (lipid). These are the main bands differentiated from normal 
serum samples (Table 1 and Fig. 2).
K-means clustering of serum spectral data
K-means clustering analysis was used to group the spectral data 
based on the similarity in forming clusters and region of similarity 
in biochemical properties. Biomolecular assignments considered for 
K-means clustering are protein, tryptophan, amide III, C-C stretch, NH 
amide III, and CH2 twist.
From Graph 1, the presence of CH2 twist is predominant and the 
occurrence of NH amide III is seen. Even though NH amide III is absent 
in cluster 2, its presence in cluster 1 and 3 indicates the significance of 
NH amide III in the sample. f-values of protein (8.162), stretch (35.185), 
NH amide III (2.866), and CO stretch (12.328) show lower values in the 
normal samples than others in malignant samples. It indicates that 
among the four parameters all of them have a highly significant impact 
on the formation of clusters.
In malignant sample clustering, represented in cluster Graph 2, all the 
biochemical assignments show high f-values compared to normal that 
is protein (26.005), CC stretch (216.339), NH amide III (8.172), and CO 
stretch (11.438). This indicates all the parameters have less impact on 
the formation of the cluster. K-means clustering clearly differentiates 
between normal and malignant breast cancer samples.
From the literature survey, it is clear that the presence of proteins and 
amino acids is predominant in cancer patients when compared to that 
of the normal persons.
CONCLUSION
Analysis of blood serum samples of healthy persons and ductal breast 
cancer patients was done using micro Raman spectroscopy. Band 
assignments corresponding to the bands in the Raman spectra are 
identified. K-means clustering was used to find out the significance of 
biochemicals such as proteins, tryptophan, amide III, CC stretch, NH 
amide III, CH2 twist, and CO stretch of amino acids in the formation of 
clusters. From the study, it is clear that the malignant sample clearly 
differs from a normal sample. It is because all the biomolecules are in 
homogeneously distributed in the malignant sample.
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Table 1: Assignment of serum Raman spectra for fingerprint region
Wavenumber (cm−1)





856 Amino acid side chain vibrations of proline and hydroxyproline 
as well as c-c vibrations of collagen backbone, tyrosine
949 949 Amide III
953 Protein (C-C stretch protein backbone, alpha-helix), lipid
1005 Phenylalanine
1008 1008 Symmetric C-C aromatic ring breathing
1168 C-C stretch amino acid
1128 Protein, lipid
1171 C-C stretch amino acids
1263 N-H bending in amide III
1330 CH2 twist and bend, CH3 deformation (protein/lipid), nuclide 
acid
1333 1333 CH2 twist and bend, CH3 deformation (protein/lipid), nuclide 
acid
1453 1453 δ (CH2) bending, δ (CH3) out-of-phase
1564 Guanine, adenine, tryptophan, and deformation mode of C=C
1659 1659 C=O stretch in amide I, amino compound I, alpha-helix
1750 C=O stretch (lipid)
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Fig. 1: (a and b) Unprocessed Raman plot of normal serum 
samples and ductal carcinoma serum samples, respectively
Fig. 2: (a and b) Raman shift to intensity plot of normal serum 
sample and ductal carcinoma serum sample, after baseline 
correction and smoothing
Graph 1: K-means clustering plot of normal serum sample
Graph 2: K-means clustering graph of ductal carcinoma patient serum 
sample
CONFLICTS OF INTEREST
We certify that regarding this paper, no actual or potential conflicts 
of interest exist. The paper is original, has not been accepted for 
publication nor is concurrently under consideration elsewhere, and 
will not be published elsewhere without the permission of the editor.
FUNDING
No financial support for research.
REFERENCES
1. Crow P, Uff JS, Farmer JA, Wright MP, Stone N. The use of Raman 
spectroscopy to identify and characterize transitional cell carcinoma 
in vitro. BJU Int 2004;93:1232-6.
2. Cauberg EC, de Bruin DM, Faber DJ, van Leeuwen TG, de la Rosette JJ, 
de Reijke TM, et al. A new generation of optical diagnostic for bladder 
cancer: Technology, diagnostic accuracy, and future applications. Eur 
Urol 2009;56:287-97.
3. Bensalah K, Tuncel A, Peshwani D, Zeltser I, Liu H, Cadeddu J, et al. 
Optical reflectance spectroscopy to differentiate a renal tumor from 
normal parenchyma. J Urol 2008;179:2010-3.
4. Bensalah K, Pantuk AJ, Rioux-Leclercq N, Thuret R, Montorsi F, 
Karakiewicz PI, et al. Positive surgical margin appears to have a 
negligible impact on survival of renal cell carcinomas treaded by 
nephron-sparing surgery. Eur Urol 2010;57:466-73.
5. Jyothi BD, Sai SB, Lakshmi BC, Begum SK, Kumar AS. Awareness on 
cervical cancer-risk assessment. Int J Pharm Pharm Sci 2018;10:111-7.
6. Elgadir MA, Salama M, Adam A. Anti-breast cancer from various 
natural sources, review. Int J Pharm Pharm Sci 2015;7:181-3.
7. Fenn MB, Xanthopoulos P, Pyrgiotakis G, Grobmyer SR, Paedalos PM, 
Hench LL. Raman spectroscopy for clinical oncology. Adv Opt Technol 
2011;2011:213783.
8. Li QB, Sun XJ, Xu YZ, Yang LM, Zhang YF, Weng SF, et al. Diagnosis 
of gastric inflammation and malignancy in endoscopic biopsies based 
on Fourier transform infrared spectroscopy. Clin Chem 2005;51:346-50.
9. Alfano RR, Tang GC, Pradan A, Lam W, Choy D, Opher E. Fluorescence 
spectra from cancerous and normal human breast and lung tissues. 
IEEE J Quantum Electron 1987;23:1806-11.
a b
a b
